Comparison of the effectiveness of two treatment regimens in patients with COVID-19
Phase 3
- Conditions
- U07.01Covid-19.COVID-19
- Registration Number
- IRCT20200328046885N1
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Definitive diagnosis of Covid-19
Inpatients
Age older than or equal to 18 years
Exclusion Criteria
Pregnant women
Breastfeeding women
People with decreased level of consciousness
Blood pressure less than 60/90 mm Hg
Respiratory rate above 24 hypoxia
Reduction of saturation less than 90%
Patients with various organ failure
Patients required mechanical ventilation at the time of admission
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Death. Timepoint: 14,3,2,1,0 days after the start of the intervention. Method of measurement: The ratio of death to total patients in each group.;Recovery and discharge from the hospital. Timepoint: End of treatment. Method of measurement: Examine the patient and perform tests.
- Secondary Outcome Measures
Name Time Method Duration of hospitalization. Timepoint: End of study. Method of measurement: File information.;Need to be admitted to the ICU (Intensive care units). Timepoint: After the intervention. Method of measurement: See the patient's clinical signs and tests.;Requires four drug treatments. Timepoint: During treatment. Method of measurement: Patient examination.